Insulet Corporation

PODDleader

Insulet makes the Omnipod — the world's only tubeless insulin delivery system. Omnipod 5 is the first tubeless automated insulin delivery (AID) system, integrating with Dexcom's CGM for closed-loop glucose management.

⇄ Compare

Produk & Pendapatan

Pangsa Pendapatan Produk

Komposisi Pendapatan ($2.3B)

Data statis (memuat keuangan langsung…)

US Omnipod (40%)

International Omnipod (55%)

Drug Delivery (5%)

Komposisi segmen dan pelanggan utama

Detail produk

Omnipod 5 (Automated Insulin Delivery)75%

Tubeless insulin pump with Omnipod 5 closed-loop system — world's first tubeless AID system.

Omnipod DASH (Traditional Pump)20%

Bluetooth-enabled tubeless pump without automated delivery.

Drug Delivery (Non-Diabetes)5%

Pod technology licensing for drug delivery beyond insulin.

Hubungan Rantai Pasok

Mitra

DexCom

Dexcom CGM integration with Omnipod 5

Dampak: critical feature

Konteks makro dan pasar

헬스케어Berita sektor

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Katalis mendatang

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Berita terkini

Memuat berita...

Analisis AI

Klik "Dapatkan Analisis AI" untuk analisis rantai pasok Insulet Corporation.

Info Perusahaan

Kantor Pusat

Acton, MA

Didirikan

2000

Karyawan

6,200

Situs Web

insulet.com

Gambaran umum sektor — 헬스케어

Berita sektor